Ghrelin does not orchestrate the metabolic changes seen in fasting but has significant effects on lipid mobilisation and substrate utilisation

European Journal of Endocrinology

Volumn 165, Issue 1, 2011, Pages 45-55

  Huda, M S B ^a   Dovey, T M ^a   Wong, S P ^a   English, P J ^a   Halford, J C G ^a   McCulloch, P ^b   Cleator, J ^a   Martin, B ^a   Cashen, J ^a   Hayden, K ^b   Ghatei, M A ^c   Bloom, S R ^c   Wilding, J P H ^a   Pinkney, J H ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; FATTY ACID; GHRELIN; GROWTH HORMONE; KETONE BODY; INSULIN; GLUCOSE; LIPID;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FEMALE; GASTRECTOMY; HORMONE ACTION; HORMONE RESPONSE; HUMAN; LIPID METABOLISM; MALE; MORBID OBESITY; PRIORITY JOURNAL; VOLUNTEER; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; GROWTH HORMONE BLOOD LEVEL; HORMONAL REGULATION; INSULIN BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GASTRECTOMY; GHRELIN; HUMANS; INSULIN; KETONE BODIES; LIPID MOBILIZATION; MALE; MIDDLE AGED; OBESITY, MORBID;

EID: 79959399831     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1122     Document Type: Article

References (40)

1. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG & Thorner MO. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion inman. Journal of Clinical Investigation 1988 81 968-975. (doi:10.1172/JCI113450)
2. Welbourne TC, Milford L & Carter P. The role of growth hormone in substrate utilization. Baillière's Clinical Endocrinology and Metabolism 1997 11 699-707. (doi:10.1016/S0950-351X(97) 80974-3)
3. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660. (doi:10.1038/45230)
4. Lucidi P, Murdolo G, Di Loreto C, De Cicco A, Parlanti N, Fanelli C, Santeusanio F, Bolli GB & De Feo P. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes 2002 51 2911-2914. (doi:10.2337/diabetes.51.10.2911)
5. Koutkia P, Schurgin S, Berry J, Breu J, Lee BS, Klibanski A & Grinspoon S. Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy women. American Journal of Physiology. Endocrinology and Metabolism 2005 289 E814-E822. (doi:10.1152/ajpendo.00093.2005)
6. Muller AF, Lamberts SW, Janssen JA, Hofland LJ, Koetsveld PV, Bidlingmaier M, Strasburger CJ, Ghigo E & Van der Lely AJ. Ghrelin drives GH secretion during fasting in man. European Journal of Endocrinology 2002 146 203-207. (doi:10.1530/eje.0.1460203)
7. Avram AM, Jaffe CA, Symons KV & Barkan AL. Endogenous circulating ghrelin does not mediate growth hormone rhythmicity or response to fasting. Journal of Clinical Endocrinology and Metabolism 2005 90 2982-2987. (doi:10.1210/jc.2004-1785)
8. Espelund U, Hansen TK, Hojlund K, Beck-Nielsen H, Clausen JT, Hansen BS, Orskov H, Jorgensen JO & Frystyk J. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. Journal of Clinical Endocrinology and Metabolism 2005 90 741-746. (doi:10.1210/jc.2004-0604)
9. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML & Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism 1991 72 51-59. (doi:10.1210/jcem-72-1-51)
10. Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, Rossetto R, Wu Z, Strasburger CJ & Ghigo E. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. International Journal of Obesity and Related Metabolic Disorders 2001 25 1233-1239. (doi:10.1038/sj.ijo.0801671)
11. Takachi K, Doki Y, Ishikawa O, Miyashiro I, Sasaki Y, Ohigashi H, Murata K, Nakajima H, Hosoda H, Kangawa K, Sasakuma F & Imaoka S. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. Journal of Surgical Research 2006 130 1-7. (doi:10.1016/j.jss.2005. 08.003)
12. Popovic V, Miljic D, Pekic S, Pesko P, Djurovic M, Doknic M, Damjanovic S, Micic D, Cvijovic G, Glodic J, Dieguez C & Casanueva FF. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. Journal of Clinical Endocrinology and Metabolism 2005 90 2187-2191. (doi:10.1210/jc.2004-1888)
13. Natalucci G, Riedl S, Gleiss A, Zidek T & Frisch H. Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. European Journal of Endocrinology 2005 152 845-850. (doi:10.1530/eje.1.01919)
14. Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C & Bloom SR. Ghrelin increases food intake in obese as well as lean subjects. International Journal of Obesity 2005 29 1130-1136. (doi:10.1038/sj.ijo.0803001)
15. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA & Bloom SR. Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 5992. (doi:10.1210/jc.86.12.5992)
16. Martin NM, Small CJ, Sajedi A, Patterson M, Ghatei MA & Bloom SR. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin. International Journal of Obesity and Related Metabolic Disorders 2004 28 886-893. (doi:10.1038/sj.ijo.0802646)
17. Tan TM, Vanderpump M, Khoo B, Patterson M, Ghatei MA & Goldstone AP. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 4162-4165. (doi:10.1210/jc.2004-0835)
18. Grottoli S, Gauna C, Tassone F, Aimaretti G, Corneli G, Wu Z, Strasburger CJ, Dieguez C, Casanueva FF, Ghigo E & Maccario M. Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity. Clinical Endocrinology 2003 58 220-228. (doi:10.1046/j.1365-2265.2003. 01699.x)
19. Ozata M, Dieguez C & Casanueva FF. The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients. Journal of Clinical Endocrinology and Metabolism 2003 88 312-316. (doi:10.1210/jc.2002-020122)
20. Chaussain JL, Georges P, Olive G & Job JC. Effect of 24 hour fast in obese children. Biomedicine 1976 25 299-302.
21. Goschke H. Mechanism of glucose intolerance during fasting: differences between lean and obese subjects. Metabolism 1977 26 1147-1153. (doi:10.1016/0026-0495(77)90042-7)
22. Zittel TT, Glatzle J, Muller M, Kreis ME, Raybould HE, Becker HD & Jehle EC. Total gastrectomy severely alters the central regulation of food intake in rats. Annals of Surgery 2002 236 166-176. (doi:10.1097/00000658- 200208000-00004)
23. Kim MS, Yoon CY, Park KH, Shin CS, Park KS, Kim SY, Cho BY & Lee HK. Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport 2003 14 1317-1320. (doi:10.1097/01.wnr.0000078703.79393.d2)
24. Bradley EL III, Isaacs J, Hersh T, Davidson ED & Millikan W. Nutritional consequences of total gastrectomy. Annals of Surgery 1975 182 415-429. (doi:10.1097/00000658-197510000-00007)
25. Vestergaard ET, Hansen TK, Gormsen LC, Jakobsen P, Moller N, Christiansen JS & Jorgensen JO. Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects. American Journal of Physiology. Endocrinology and Metabolism 2007 292 E1829-E1836. (doi:10.1152/ajpendo.00682.2006)
26. Vestergaard ET, Gormsen LC, Jessen N, Lund S, Hansen TK, Moller N & Jorgensen JO. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 2008 57 3205-3210. (doi:10.2337/db08-0025)
27. Tschop M, Smiley DL & Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000 407 908-913. (doi:10.1038/35038090)
28. Kelley DE, Goodpaster B, Wing RR & Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. American Journal of Physiology 1999 277 E1130-E1141. (Pubitemid 30046009)
29. Storlien L, Oakes ND & Kelley DE. Metabolic flexibility. Proceedings of the Nutrition Society 2004 63 363-368. (doi:10.1079/PNS2004349)
30. Huda MS, Dovey T, Wong SP, English PJ, Halford J, McCulloch P, Cleator J, Martin B, Cashen J, Hayden K, Wilding JP & Pinkney J. Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects. International Journal of Obesity 200933317-325. (doi:10.1038/ijo.2008.270)
31. Lucidi P, Murdolo G, Di Loreto C, Parlanti N, De Cicco A, Fatone C, Taglioni C, Fanelli C, Broglio F, Ghigo E, Bolli GB, Santeusanio F & De Feo P. Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations. Nutrition, Metabolism, and Cardiovascular Diseases 2005 15 410-417. (doi:10.1016/j.numecd.2005.02.006)
32. Foster DW & McGarry JD. The regulation of ketogenesis. Ciba Foundation Symposium 1982 87 120-131.
33. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van der Lely AJ & Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism 2004893062-3065. (doi:10.1210/jc.2003- 031964)
34. Neary NM, Druce MR, Small CJ & Bloom SR. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 2006 55 135. (Pubitemid 41820653)
35. Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci M, Dore F, Fonda M, Ciocchi B, Cattin L & Guarnieri G. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 3935-3940. (doi:10.1210/jc.2006-2527)
36. Pacifico L, Poggiogalle E, Costantino F, Anania C, Ferraro F, Chiarelli F & Chiesa C. Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome. European Journal of Endocrinology 2009 161 861-870. (doi:10.1530/EJE-09-0375)
37. Liu J, Prudom CE, Nass R, Pezzoli SS, Oliveri MC, Johnson ML, Veldhuis P, Gordon DA, Howard AD, Witcher DR, Geysen HM, Gaylinn BD & Thorner MO. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. Journal of Clinical Endocrinology and Metabolism 2008 93 1980-1987. (doi:10.1210/jc.2007-2235)
38. Morash MG, Gagnon J, Nelson S & Anini Y. Tissue distribution and effects of fasting and obesity on the ghrelin axis in mice. Regulatory Peptides 2010 163 62-73. (doi:10.1016/j.regpep.2010.03.010)
39. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL & Brown MS. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. PNAS 2010 107 7467-7472. (doi:10.1073/pnas.1002271107)
40. Holmes E, Davies I, Lowe G & Ranganath LR. Circulating ghrelin exists in both lipoprotein bound and free forms. Annals of Clinical Biochemistry 2009 46 514-516. (doi:10.1258/acb.2009.008254)